Lexpos News

/Lexpos News

MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited)

MHRA Class 2 Medicines Notification: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) Drug alert number: EL(25)A/29 Date issued: 25 June 2025 A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct [...]

The post MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) appeared first on Community Pharmacy England.

By |June 25th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited)

DMS: Have you claimed for completed activity?

Following the announcement of a new streamlined process for making claims for the Discharge Medicines Service (DMS), pharmacy owners are reminded of the actions they need to take ahead of this coming into effect on 6th July 2025. Claims Action Claims up to and including 30th June 2025 All DMS activity up until 30th June [...]

The post DMS: Have you claimed for completed activity? appeared first on Community Pharmacy England.

By |June 25th, 2025|Lexpos News|Comments Off on DMS: Have you claimed for completed activity?

New application route to rearrange core opening hours

Today, the new application route for rearranging core opening hours came into force. This follows on from the laying of the relevant regulations in Parliament on 2 June, see our announcement. The new application route The new application route – which is available in addition to the pre-existing route – has a single regulatory test. [...]

The post New application route to rearrange core opening hours appeared first on Community Pharmacy England.

By |June 23rd, 2025|Lexpos News|Comments Off on New application route to rearrange core opening hours

SSP for Venlafaxine 37.5mg modified-release tablets issued

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.

By |June 23rd, 2025|Lexpos News|Comments Off on SSP for Venlafaxine 37.5mg modified-release tablets issued

Strengthening our voice: LPC Chairs and MPs meet to discuss future of pharmacy

LPC Chairs and Community Pharmacy England have met with MPs to discuss the value that pharmacies bring to local communities, as well as ways to address the continued pressures facing the sector. The Forum of LPC Chairs held in Parliament this week focussed on efforts to build an ever-stronger local voice for community pharmacy, including [...]

The post Strengthening our voice: LPC Chairs and MPs meet to discuss future of pharmacy appeared first on Community Pharmacy England.

By |June 23rd, 2025|Lexpos News|Comments Off on Strengthening our voice: LPC Chairs and MPs meet to discuss future of pharmacy